Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Sarah C Darby has been elected a Fellow of the Royal Society in recognition of her exceptional contribution to science. 

Sarah is Professor of Medical Statistics in the Nuffield Department of Population Health. She is a statistical epidemiologist who has formulated and studied several questions regarding the impact of ionising radiation on human health. She studied Mathematics at Imperial College London, Mathematical Statistics at the University of Birmingham, and Medical Statistics at the London School of Hygiene and Tropical Medicine. She then worked at St Thomas’s Hospital Medical School, the National Radiological Protection Board, and the Radiation Effects Research Foundation in Hiroshima, before moving to the University of Oxford in 1984. Since then her major funder has been Cancer Research UK.

Sarah and her team have demonstrated that there is a linear relationship between the dose of radiation delivered incidentally to the heart during breast cancer radiotherapy and the subsequent risk of ischaemic heart disease, and that the absolute size of the radiation-related risk is bigger for women already at increased risk of heart disease.   

She and her team have also estimated the absolute size of the benefit of radiotherapy to breast cancer patients and their work is enabling comparison of the likely absolute benefit of radiotherapy with its likely absolute risk for individual patients. Therefore it is now becoming possible to assess which patients can receive standard radiotherapy, which should be considered for advanced techniques, and which should avoid radiotherapy altogether.  

Other topics that Sarah has worked on include estimating the risk of lung cancer from residential radon, the risk of invasive breast cancer after a diagnosis of ductal carcinoma in situ, and the risk of cancer after computerised tomography scans in young people.  

Sarah is one of 50 eminent scientists who have been elected Fellows of the Royal Society, alongside 10 new Foreign Members. Venki Ramakrishnan, President of the Royal Society, says: ‘Over the course of the Royal Society’s vast history, it is our Fellowship that has remained a constant thread and the substance from which our purpose has been realised: to use science for the benefit of humanity. 

‘This year’s newly elected Fellows and Foreign Members of the Royal Society embody this, being drawn from diverse fields of enquiry—epidemiology, geometry, climatology—at once disparate, but also aligned in their pursuit and contributions of knowledge about the world in which we live, and it is with great honour that I welcome them as Fellows of the Royal Society.’ 

A formal Admissions Day ceremony will take place in July.

Similar stories

Travels with Vignesh

CRM General

Vignesh Murugesan, a Postdoctoral Researcher in Department of Physiology, Anatomy & Genetics (DPAG), describes how he found his way from the large metropolitan town of Chennai in India to studying regenerative medicine here in Oxford, via an 8 year stint in Sweden.

Genetic breakthrough to target care for deadly heart condition

CRE Research

Professor Watkins and his team have found a new type of genetic change in the DNA of people with hypertrophic cardiomyopathy (HCM) - a silent killer amongst families that can cause sudden death in young people due to the thickening of the heart muscle.

Earliest origins of the forming heart identified

CRE Research

The earliest known progenitor of the outermost layer of the heart has been characterised for the first time and linked to the development of other critical cell types in the developing heart in a new paper from the Srinivas group led by BHF Immediate Fellow Dr Richard Tyser.

Professor Sir Rory Collins awarded the MRC Millennium Medal 2020

CRE Research

Professor Sir Rory Collins, Head of the Nuffield Department of Population Health, and Principal Investigator and Chief Executive of UK Biobank, has been awarded the Medical Research Council (MRC) Millennium Medal 2020, the MRC’s most prestigious personal award.

New MRI technique could detect early signs of heart failure in cancer patients following chemotherapy

CRE Publication Research

New research led by Oxford BHF CRE Intermediate Transition Fellow Dr Kerstin Timm shows that a recently developed imaging technique pioneered by the Tyler Group can detect early metabolic changes in the heart caused by a commonly used chemotherapy drug, which is known to increase risk of heart failure in cancer survivors.